Search Results

Current treatment options for psoriatic arthritis: spotlight on abatacept

• Authors : Ursini, Francesco; Russo, Emilio; De Giorgio, Roberto

• Source: Therapeutics and Clinical Risk Management. Annual, 2018, Vol. 14, p1053, 7 p.

Record details

New Rheumatoid Arthritis Research from Aalborg University Hospital Outlined (Cancer risk with tocilizumab/sarilumab, abatacept, and rituximab treatment in patients with rheumatoid arthritis: a Danish cohort study).

Subjects: DISEASE risk factors; ABATACEPT; RITUXIMAB

• Source: Immunotherapy Weekly; 2024, p684-684, 1p

Record details

Studies from State University of Campinas (UNICAMP) Yield New Data on Rheumatoid Arthritis (Compared efficacy of rituximab, abatacept, and tocilizumab in patients with rheumatoid arthritis refractory to methotrexate or TNF inhibitors agents: a...).

Subjects: RITUXIMAB; RHEUMATOID arthritis; ABATACEPT

• Source: Immunotherapy Weekly; 7/25/2023, p1718-1718, 1p

Record details

Reports Outline Rheumatoid Arthritis Findings from Rigshospitalet (Certolizumab Pegol, Abatacept, Tocilizumab or Active Conventional Treatment In Early Rheumatoid Arthritis: 48-week Clinical and Radiographic Results of the...).

Subjects: CERTOLIZUMAB pegol; ABATACEPT; TOCILIZUMAB

• Source: Immunotherapy Weekly; 9/14/2023, p2191-2191, 1p

Record details

Comparative effectiveness of abatacept, apremilast, secukinumab and ustekinumab treatment of psoriatic arthritis: a systematic review and network meta-analysis.

• Authors : Kawalec, P.; Holko, P.; Moćko, P.

Subjects: PSORIATIC arthritis; ABATACEPT; DRUG efficacy

• Source: Rheumatology International; Feb2018, Vol. 38 Issue 2, p189-201, 13p

Record details

Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies.

• Authors : Hirabara, Shinya; Takahashi, Nobunori; Fukaya, Naoki

Subjects: HEALTH outcome assessment; RHEUMATOID arthritis treatment; ABATACEPT

• Source: Clinical Rheumatology; Sep2014, Vol. 33 Issue 9, p1247-1254, 8p, 2 Charts, 3 Graphs

Record details

Non‐Redundant Roles of T Cell Costimulation Pathways in Inflammatory Arthritis Revealed by Dual Blockade of ICOS and CD28 with Acazicolcept (ALPN‐101).

• Authors : Dillon, Stacey R.; Evans, Lawrence S.; Lewis, Katherine E.

Subjects: IN vitro studies; CYTOKINES; IMMUNOGLOBULINS

• Source: Arthritis & Rheumatology; Aug2023, Vol. 75 Issue 8, p1344-1356, 13p

Record details

The balance between Foxp3 and Ror-γt expression in peripheral blood is altered by tocilizumab and abatacept in patients with rheumatoid arthritis.

• Authors : Yoshifumi Tada; Nobuyuki Ono; Rie Suematsu

Subjects: SCURFIN (Protein); FORKHEAD transcription factors; T cells

• Source: BMC Musculoskeletal Disorders; 7/16/2016, Vol. 17, p1-7, 7p, 1 Chart, 3 Graphs

Record details

Evaluation of cost-effectiveness of various drugs used in the treatment of rheumatoid arthritis: An observational and prospective study.

• Authors : Neha K.; Ravishankar V.; Kumar G., Chethan

Subjects: ABATACEPT; ANTIRHEUMATIC agents; RHEUMATOID arthritis

• Source: National Journal of Physiology, Pharmacy & Pharmacology; 2023, Vol. 13 Issue 12, p2496-2499, 4p

Record details

Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritis.

• Authors : Bonelli, Michael; Göschl, Lisa; Blüml, Stephan

Subjects: APOPTOSIS; C-reactive protein; STATISTICAL correlation

• Source: Rheumatology; Apr2016, Vol. 55 Issue 4, p710-720, 11p, 1 Chart, 5 Graphs

Record details